| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_031e38790e7d1bcc91bca41f0eec7ce1 |
| classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12Q1-6827
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12Q1-6806
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12Q2600-156
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12Q2600-118
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12Q2531-113
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12Q2561-113
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12Q1-686
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12Q1-6858
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N33-50 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12Q1-68
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G01N33-50 |
| filingDate |
2016-10-04-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate |
2017-05-26-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_0873cd276cd02d31afe6e8be3fd37d6e
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_278b82c8f48a7ff83416935682026392
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_5dfc19fc539a6c767ca63d5f4035907b
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_c7a279b36d36ca3f0113e9e5f4344e8f
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_597be3ea86da6398c3c31892d662ffec
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_4084bd47707b0163b5b17aa9f40f7fc3 |
| publicationDate |
2017-05-26-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
RU-2620566-C1 |
| titleOfInvention |
Prediction method of arterial hypertension comorbide form and chronic obstructive pulmonary disease development |
| abstract |
FIELD: medicine. n SUBSTANCE: invention is intended to predict development of comorbide form of arterial hypertension (AH) and chronic obstructive pulmonary disease (COPD). Genotypes of M235T polymorphic locus of angiotensinogen gene (AGT) and A1166C polymorphic locus of angiotensin II receptor gene of I type (AGTR1) are determined in patient with AH or COPD. If a patient has T/T M235T polymorphic locus genotype of AGT gene and A/C A1166C polymorphic locus genotype of AGTR1 gene, high probability of comorbide AH and COPD development within 10 years after the onset of the first disease is predicted. n EFFECT: invention enables to predict the development of comorbidd AH and COPD with a high probability. n 2 cl, 1 dwg, 10 tbl, 4 ex |
| isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/RU-2711453-C1 |
| priorityDate |
2016-10-04-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |